What Changes are in Store for the Cancer Drug Fund?

The National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England have proposed changes to the operation of the Cancer Drugs Funds. Why does the fund need reform and what will that reform look like? See more here. (Source: Pharmafile, 1/14/16)

You might also be interested in:

Report: NHS Failing to Treat Common Causes of Death June 26, 2018
NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
Are Vertex, NHS Close to CF Drug Pricing Deal? April 24, 2018
NICE Rejects MS Drug Ocrevus; MS Society Files Petition September 11, 2018
U.K. Ruling Could Save NHS ‘Hundreds of Millions’ Annually September 22, 2018
NICE Backs EUSA Pharma’s Qarziba July 15, 2018
PhRMA Responds to OIG’s Rebate Proposal April 9, 2019